Type 2 diabetes is a common condition where the body struggles to use insulin properly, leading to high blood sugar levels.
One of the most widely used treatments for this is metformin, a medication that helps lower blood sugar.
However, for many people, metformin alone is not enough to keep their diabetes under control over time. This often leads doctors to explore additional treatments to better manage blood sugar levels.
Researchers at Thomas Jefferson University recently discovered a promising new combination of two diabetes medications that could make a big difference for people whose blood sugar is not well-managed with metformin alone.
This new approach not only improves blood sugar control but also continues to work effectively over time. This breakthrough brings fresh hope to those who have been struggling to manage their diabetes.
The two medications in this combination are dapagliflozin and exenatide. To understand how well these drugs work together, scientists conducted a large study involving 695 adults with Type 2 diabetes. All participants were already taking metformin, but their blood sugar levels were not well-controlled.
The researchers divided the participants into three groups. The first group received weekly injections of exenatide along with metformin. The second group took daily dapagliflozin pills in addition to metformin. The third group received both dapagliflozin and exenatide along with metformin.
The results were remarkable. Those who took both dapagliflozin and exenatide together had much better blood sugar control than those who took only one of the drugs. Even more impressive, these benefits lasted throughout the entire two years of the study. This long-term effectiveness is especially important because many diabetes treatments lose their impact over time.
What makes this combination so powerful is that the two drugs work in different ways. Dapagliflozin helps the kidneys remove excess sugar from the body by flushing it out through urine. This process helps lower blood sugar levels without relying solely on insulin.
On the other hand, exenatide boosts insulin production when you eat, reduces the amount of sugar made by the liver, slows down how fast food leaves your stomach, and helps you feel full longer. Together, they tackle different parts of blood sugar control, creating a stronger overall effect.
In addition to lowering blood sugar, the combination therapy also led to weight loss and better blood pressure control. These are important benefits for people with Type 2 diabetes, as both weight and blood pressure are often linked to diabetes complications.
Safety is always a concern with new treatments, but the study found that the combination of dapagliflozin and exenatide was safe. Participants did not experience any unexpected side effects, which is reassuring for anyone considering this new treatment option.
The findings were published in the journal Diabetes Care, and Dr. Serge Jabbour, the lead researcher, highlighted the impact this discovery could have on diabetes treatment in the future. For people who find that metformin is no longer enough to manage their diabetes, this new combination provides an effective and safe option.
This research marks an important step forward in managing Type 2 diabetes. The combination of dapagliflozin and exenatide not only helps control blood sugar but also supports weight loss and blood pressure improvement. This makes it an appealing choice for those needing more support than metformin alone can provide.
For many people living with Type 2 diabetes, this discovery brings renewed hope. It offers a new way to keep blood sugar levels steady over the long term, making it easier to manage the condition and reduce the risk of complications.
If you care about diabetes, please read studies that MIND diet may reduce risk of vision loss disease, and Vitamin D could benefit people with diabetic neuropathic pain.
For more information about diabetes, please see recent studies that Vitamin E could help reduce blood sugar and insulin resistance in diabetes, and results showing eating eggs in a healthy diet may reduce risks of diabetes, high blood pressure.
Copyright © 2025 Knowridge Science Report. All rights reserved.
